Estimating the Number Needed to Vaccinate to Prevent Herpes Zoster-related Disease, Health Care Resource Use and MortalityBRISSON, Marc.Canadian journal of public health. 2008, Vol 99, Num 5, pp 383-386, issn 0008-4263, 4 p.Article

Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A PrimerJIT, Mark; BRISSON, Marc.PharmacoEconomics (Auckland). 2011, Vol 29, Num 5, pp 371-386, issn 1170-7690, 16 p.Article

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsPELLISSIER, James M; BRISSON, Marc; LEVIN, Myron J et al.Vaccine. 2007, Vol 25, Num 49, pp 8326-8337, issn 0264-410X, 12 p.Article

Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11BRISSON, Marc; VAN DE VELDE, Nicolas; BOILY, Marie-Claude et al.Sexually transmitted infections. 2011, Vol 87, Num 1, pp 41-43, issn 1368-4973, 3 p.Article

Modeling human papillomavirus vaccine effectiveness : Quantifying the impact of parameter uncertaintyVAN DE VELDE, Nicolas; BRISSON, Marc; BOILY, Marie-Claude et al.American journal of epidemiology. 2007, Vol 165, Num 7, pp 762-775, issn 0002-9262, 14 p.Article

Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysisVAN DE VELDE, Nicolas; BRISSON, Marc; BOILY, Marie-Claude et al.Vaccine. 2010, Vol 28, Num 33, pp 5473-5484, issn 0264-410X, 12 p.Article

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model―Based AnalysisVAN DE VELDE, Nicolas; BOILY, Marie-Claude; DROLET, Melanie et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 22, pp 1712-1723, issn 0027-8874, 12 p.Article

Loss of quality of life associated with genital warts: baseline analyses from a prospective studySENECAL, Martin; BRISSON, Marc; MAUNSELL, Elizabeth et al.Sexually transmitted infections. 2011, Vol 87, Num 3, pp 209-215, issn 1368-4973, 7 p.Article

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in CanadaBRISSON, Marc; VAN DE VELDE, Nicolas; DE WATS, Philippe et al.Vaccine. 2007, Vol 25, Num 29, pp 5399-5408, issn 0264-410X, 10 p.Article

The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: A model-based analysisMALAGON, Talia; JOUMIER, Véronique; BOILY, Marie-Claude et al.Vaccine. 2013, Vol 31, Num 13, pp 1740-1747, issn 0264-410X, 8 p.Article

A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophyANIS, Aslam H; HUIYING SUN; SINGH, Sonia et al.PharmacoEconomics (Auckland). 2006, Vol 24, Num 4, pp 387-400, issn 1170-7690, 14 p.Article

The potential cost-effectiveness of acellular pertussis booster vaccination in England and WalesEDMUNDS, W. John; BRISSON, Marc; MELEGARO, Alessia et al.Vaccine. 2002, Vol 20, Num 9-10, pp 1316-1330, issn 0264-410XArticle

HEALTH-RELATED QUALITY OF LIFE LOST TO ROTAVIRUS-ASSOCIATED GASTROENTERITIS IN CHILDREN AND THEIR PARENTS: A CANADIAN PROSPECTIVE STUDYBRISSON, Marc; SENECAL, Martin; DROLET, Mélanie et al.The Pediatric infectious disease journal. 2010, Vol 29, Num 1, pp 73-75, issn 0891-3668, 3 p.Article

Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccineDROLET, Mélanie; LAPRISE, Jean-François; BOILY, Marie-Claude et al.International journal of cancer (Print). 2014, Vol 134, Num 9, pp 2264-2268, issn 0020-7136, 5 p.Article

The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective StudyDROLET, Mélanie; BRISSON, Marc; MAUNSELL, Elizabeth et al.Sexually transmitted diseases. 2011, Vol 38, Num 10, pp 949-956, issn 0148-5717, 8 p.Article

Twenty-Year Trends in the Incidence and Prevalence of Diagnosed Anogenital Warts in CanadaKLIEWER, Erich V; DEMERS, Alain A; ELLIOTT, Lawrence et al.Sexually transmitted diseases. 2009, Vol 36, Num 6, pp 380-386, issn 0148-5717, 7 p.Article

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisMALAGON, Talía; DROLET, Mélanie; BOILY, Marie-Claude et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 10, pp 781-789, issn 1473-3099, 9 p.Article

Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd ImmunityBRISSON, Marc; VAN DE VELDE, Nicolas; FRANCO, Eduardo L et al.The Journal of infectious diseases. 2011, Vol 204, Num 3, pp 372-376, issn 0022-1899, 5 p.Article

Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zosterBRISSON, Marc; MELKONYAN, Gurgen; DROLET, Melanie et al.Vaccine. 2010, Vol 28, Num 19, pp 3385-3397, issn 0264-410X, 13 p.Article

Modeling Cervical Cancer Prevention in Developed CountriesKIM, Jane J; BRISSON, Marc; EDMUNDS, W. John et al.Vaccine. Supplement. 2008, Vol 26, Num 10, issn 1359-5938, K76-K86Article

Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: A transmission-dynamic modeling studyBRISSON, Marc; LAPRISE, Jean-François; DROLET, Mélanie et al.Vaccine. 2013, Vol 31, Num 37, pp 3863-3871, issn 0264-410X, 9 p.Article

Sociodemographic Inequalities in Sexual Activity and Cervical Cancer Screening: Implications for the Success of Human Papillomavirus VaccinationDROLET, Mélanie; BOILY, Marie-Claude; GREENAWAY, Christina et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 4, pp 641-652, issn 1055-9965, 12 p.Article

A Prospective Study of the Herpes Zoster Severity of IllnessDROLET, Mélanie; BRISSON, Marc; LEVIN, Myron J et al.The Clinical journal of pain. 2010, Vol 26, Num 8, pp 656-666, issn 0749-8047, 11 p.Article

Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling studyLAPRISE, Jean-François; DROLET, Mélanie; BOILY, Marie-Claude et al.Vaccine. 2014, Vol 32, Num 44, pp 5845-5853, issn 0264-410X, 9 p.Article

Two-dose strategies for human papillomavirus vaccination: How well do they need to protect?JIT, Mark; YOON HONG CHOI; LAPRISE, Jean-François et al.Vaccine. 2014, Vol 32, Num 26, pp 3237-3242, issn 0264-410X, 6 p.Article